ArticleFrontiers in endocrinology2026
Paternal age and sperm DNA fragmentation independently affect embryonic ploidy but not euploid embryo implantation potential.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically evaluate the associations between paternal factors (age, semen parameters, body mass index, sperm DNA fragmentation index (DFI), and leukocyte count), embryonic ploidy, and the clinical implantation potential of euploid embryos. Design: Single-center retrospective cohort study. Subjects: Couples who underwent intracytoplasmic sperm injection and simultaneous preimplantation genetic testing for aneuploidy between May 2019 and September 2024, with control for maternal confounding factors. Main outcome measures: (1) The association between paternal factors and the risk of embryonic aneuploidy, derived using generalized estimating equations, with individual embryos as the unit of analysis (2). The association between paternal factors and clinical pregnancy outcomes, with individual euploid blastocyst transfer cycles as the unit of analysis. Results: We analyzed 1,410 biopsied embryos (euploid group: 744 embryos; aneuploid group: 666 embryos). Multivariate analysis revealed that advanced paternal age (≥ 35 years) and high DFI (≥ 20%) were independent risk factors for the formation of embryonic aneuploidy, with risks increasing with higher age and DFI (e.g., age ≥ 40 years: OR = 2.033; DFI ≥ 30%: OR = 2.206). The association between paternal age and aneuploidy appeared to be associated with chromosomes 6, 18, and 22, whereas high DFI manifested as a broad genomic instability effect. Both factors were associated with a reduced incidence of X-chromosome abnormalities, which may be explained by early embryonic selective elimination. Subsequent analysis of 307 euploid embryo transfer cycles revealed that no paternal indicators were significantly associated with clinical pregnancy rates. Conclusion: Advanced paternal age and high DFI are key risk factors for embryonic aneuploidy; however, their negative effects were primarily related to chromosome composition. Once euploid embryos are obtained, these paternal factors do not have a significant independent effect on subsequent implantation potential. Our findings suggest that clinical efforts should differ across treatment stages: early treatment should prioritize active management of male factors to improve euploid embryo yield, whereas treatment during the transfer phase should prioritize optimizing maternal uterine receptivity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.